| Dr Arnold O Hopland, MD | |
|
1500 W Elk Ave, Elizabethton, TN 37643-2654 | |
| (423) 543-2584 | |
| (423) 722-2060 |
| Full Name | Dr Arnold O Hopland |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 1500 W Elk Ave, Elizabethton, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689674681 | NPI | - | NPPES |
| Q026446 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 12764 (Tennessee) | Primary |
| Entity Name | Medical Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851537260 PECOS PAC ID: 1850448580 Enrollment ID: O20090414000752 |
News Archive
Youjia Guo et al. in a recent bioRxiv preprint paper demonstrate the robust performance of mouse anti-SARS-CoV-2 spike monoclonal antibodies in immunoassays, including western blotting, ELISA, immunofluorescence, and immunoprecipitation and also neutralizing activity in vitro against SARS-CoV-2 infection.
The British government, as part of it's fight against 'superbugs' such as methicillin-resistant Staphylococcus aureu (MRSA) and Clostridium difficile, has promised every hospital the funds to recruit four specialist nurses to help curb the infections.
In an ongoing effort to support breast cancer awareness, education and research, Bright Starts announces the winners of its fourth annual Pink Power Mom search. The winners are eight inspirational mothers who have survived (or are currently battling) breast cancer and have used their experience to make a profound difference in the lives of other women affected by the disease
The Nurse Practitioners' Association of Ontario (NPAO) applauds the McGuinty government for their announcement today to fund three new Nurse Practitioner (NP) Led Clinics in Belle River, Sault Ste. Marie and Thunder Bay.
ThromboGenics NV, a biopharmaceutical company focused on innovative medicines for eye disease, vascular disease and cancer, announces today that it has started a Phase II trial of microplasmin for the treatment of exudative (wet) Age-related Macular Degeneration (AMD).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arnold O Hopland, MD 401 E Main St, Johnson City, TN 37601-4877 Ph: (423) 722-2057 | Dr Arnold O Hopland, MD 1500 W Elk Ave, Elizabethton, TN 37643-2654 Ph: (423) 543-2584 |
News Archive
Youjia Guo et al. in a recent bioRxiv preprint paper demonstrate the robust performance of mouse anti-SARS-CoV-2 spike monoclonal antibodies in immunoassays, including western blotting, ELISA, immunofluorescence, and immunoprecipitation and also neutralizing activity in vitro against SARS-CoV-2 infection.
The British government, as part of it's fight against 'superbugs' such as methicillin-resistant Staphylococcus aureu (MRSA) and Clostridium difficile, has promised every hospital the funds to recruit four specialist nurses to help curb the infections.
In an ongoing effort to support breast cancer awareness, education and research, Bright Starts announces the winners of its fourth annual Pink Power Mom search. The winners are eight inspirational mothers who have survived (or are currently battling) breast cancer and have used their experience to make a profound difference in the lives of other women affected by the disease
The Nurse Practitioners' Association of Ontario (NPAO) applauds the McGuinty government for their announcement today to fund three new Nurse Practitioner (NP) Led Clinics in Belle River, Sault Ste. Marie and Thunder Bay.
ThromboGenics NV, a biopharmaceutical company focused on innovative medicines for eye disease, vascular disease and cancer, announces today that it has started a Phase II trial of microplasmin for the treatment of exudative (wet) Age-related Macular Degeneration (AMD).
› Verified 6 days ago